Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death

Detalhes bibliográficos
Autor(a) principal: Nascimento,Maria Isabel do
Data de Publicação: 2013
Outros Autores: Cunha,Alfredo de Almeida, Oliveira,Sandra Regina dos Santos Muri, Nunes,Glaucimara Gonzaga, Alvarez,Felipe Silva, Villas Bôas,Eduardo Loyola
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000400014
Resumo: OBJECTIVE: To analyze the misoprostol use in pregnancies with intrauterine fetal death (IUFD), considering mode of delivery and induction-delivery interval. METHODS: Descriptive study including 171 pregnant women with IUFD, in the second or third trimester, submitted to labor induction with vaginal misoprostol and/or induction/augmentation with intravenous oxytocin, from 2005 to 2008, at a teaching-hospital of the Brazilian Unified Health System (Sistema Único de Saúde -SUS). RESULTS: Misoprostol alone (treatment A), misoprostol plus oxytocin (treatment B), and oxytocin alone (treatment C) were administered in 9.3%, 19.9%, and 70.8% of the cases, respectively. One-third of pregnancies were less than 28 weeks, and 2.9% required a caesarean section. The percentage of vaginal delivery in treatments A and B combined (98.0%) was similar to treatment C (96.7%). The mean induction-delivery interval was 15.4 hours. Comparing multiple groups, the mean induction-delivery interval was significantly shorter in treatment A (20.1 hours) than in treatment B (33.3 hours), and was longer than in treatment C (9.7 hours). The majority (71%) of cases required a single administration of misoprostol, and the total dosage was lower in treatment A (mean: 98.4 µg) compared with treatment B (mean: 157.0 µg). CONCLUSION: Misoprostol effectively contributed to delivery of IUFD by vaginal route assisted under routine conditions of a public health service in Brazil, demonstrating its importance in cases resistant to usual induction methods, and its availability in Brazilian public health services is recommended.
id AMB-1_52816635c099ef312cef82ad99197d88
oai_identifier_str oai:scielo:S0104-42302013000400014
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal deathMisoprostolOxytocinLabor inducedDelivery obstetricFetal deathStillbirthOBJECTIVE: To analyze the misoprostol use in pregnancies with intrauterine fetal death (IUFD), considering mode of delivery and induction-delivery interval. METHODS: Descriptive study including 171 pregnant women with IUFD, in the second or third trimester, submitted to labor induction with vaginal misoprostol and/or induction/augmentation with intravenous oxytocin, from 2005 to 2008, at a teaching-hospital of the Brazilian Unified Health System (Sistema Único de Saúde -SUS). RESULTS: Misoprostol alone (treatment A), misoprostol plus oxytocin (treatment B), and oxytocin alone (treatment C) were administered in 9.3%, 19.9%, and 70.8% of the cases, respectively. One-third of pregnancies were less than 28 weeks, and 2.9% required a caesarean section. The percentage of vaginal delivery in treatments A and B combined (98.0%) was similar to treatment C (96.7%). The mean induction-delivery interval was 15.4 hours. Comparing multiple groups, the mean induction-delivery interval was significantly shorter in treatment A (20.1 hours) than in treatment B (33.3 hours), and was longer than in treatment C (9.7 hours). The majority (71%) of cases required a single administration of misoprostol, and the total dosage was lower in treatment A (mean: 98.4 µg) compared with treatment B (mean: 157.0 µg). CONCLUSION: Misoprostol effectively contributed to delivery of IUFD by vaginal route assisted under routine conditions of a public health service in Brazil, demonstrating its importance in cases resistant to usual induction methods, and its availability in Brazilian public health services is recommended.Associação Médica Brasileira2013-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000400014Revista da Associação Médica Brasileira v.59 n.4 2013reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1016/j.ramb.2013.02.005info:eu-repo/semantics/openAccessNascimento,Maria Isabel doCunha,Alfredo de AlmeidaOliveira,Sandra Regina dos Santos MuriNunes,Glaucimara GonzagaAlvarez,Felipe SilvaVillas Bôas,Eduardo Loyolaeng2015-07-28T00:00:00Zoai:scielo:S0104-42302013000400014Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2015-07-28T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death
title Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death
spellingShingle Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death
Nascimento,Maria Isabel do
Misoprostol
Oxytocin
Labor induced
Delivery obstetric
Fetal death
Stillbirth
title_short Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death
title_full Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death
title_fullStr Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death
title_full_unstemmed Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death
title_sort Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death
author Nascimento,Maria Isabel do
author_facet Nascimento,Maria Isabel do
Cunha,Alfredo de Almeida
Oliveira,Sandra Regina dos Santos Muri
Nunes,Glaucimara Gonzaga
Alvarez,Felipe Silva
Villas Bôas,Eduardo Loyola
author_role author
author2 Cunha,Alfredo de Almeida
Oliveira,Sandra Regina dos Santos Muri
Nunes,Glaucimara Gonzaga
Alvarez,Felipe Silva
Villas Bôas,Eduardo Loyola
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Nascimento,Maria Isabel do
Cunha,Alfredo de Almeida
Oliveira,Sandra Regina dos Santos Muri
Nunes,Glaucimara Gonzaga
Alvarez,Felipe Silva
Villas Bôas,Eduardo Loyola
dc.subject.por.fl_str_mv Misoprostol
Oxytocin
Labor induced
Delivery obstetric
Fetal death
Stillbirth
topic Misoprostol
Oxytocin
Labor induced
Delivery obstetric
Fetal death
Stillbirth
description OBJECTIVE: To analyze the misoprostol use in pregnancies with intrauterine fetal death (IUFD), considering mode of delivery and induction-delivery interval. METHODS: Descriptive study including 171 pregnant women with IUFD, in the second or third trimester, submitted to labor induction with vaginal misoprostol and/or induction/augmentation with intravenous oxytocin, from 2005 to 2008, at a teaching-hospital of the Brazilian Unified Health System (Sistema Único de Saúde -SUS). RESULTS: Misoprostol alone (treatment A), misoprostol plus oxytocin (treatment B), and oxytocin alone (treatment C) were administered in 9.3%, 19.9%, and 70.8% of the cases, respectively. One-third of pregnancies were less than 28 weeks, and 2.9% required a caesarean section. The percentage of vaginal delivery in treatments A and B combined (98.0%) was similar to treatment C (96.7%). The mean induction-delivery interval was 15.4 hours. Comparing multiple groups, the mean induction-delivery interval was significantly shorter in treatment A (20.1 hours) than in treatment B (33.3 hours), and was longer than in treatment C (9.7 hours). The majority (71%) of cases required a single administration of misoprostol, and the total dosage was lower in treatment A (mean: 98.4 µg) compared with treatment B (mean: 157.0 µg). CONCLUSION: Misoprostol effectively contributed to delivery of IUFD by vaginal route assisted under routine conditions of a public health service in Brazil, demonstrating its importance in cases resistant to usual induction methods, and its availability in Brazilian public health services is recommended.
publishDate 2013
dc.date.none.fl_str_mv 2013-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000400014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000400014
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.ramb.2013.02.005
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.59 n.4 2013
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212830761975808